TVM Capital Healthcare exits Cambridge Medical and Rehabilitation Center for US$ 232 Million, a 4.6x return on capital invested

TVM Capital Healthcare has a long track record of successfully investing in and growing specialty care companies with investment and operation teams in the MENA region and Southeast Asia

  

Singapore/Dubai/Boston/Munich: TVM Capital Healthcare, a global specialist healthcare private equity firm operating in emerging markets, announces the successful sale of its portfolio company Cambridge Medical and Rehabilitation Center (“CMRC”) to UAE-based publicly traded investment company, Amanat Holdings PJSC. CMRC is the leading post-acute care and rehabilitation services provider in the MENA region. TVM Capital Healthcare has a long track record of successfully investing in and growing specialty care companies with investment and operation teams in the MENA region and Southeast Asia.

The sale of CRMC represents the third successful exit of the $134 million funds managed and arranged by TVM Capital Healthcare. Distribution to investors of Paid-In capital (DPI) amounts to 2.4x funds invested to date, with two companies still in the portfolio. Compounded returns amount to 28.0% Gross IRR / 19.7% Net IRR, a performance in the Upper Quartile of similar vintage funds, benchmarked against Cambridge Associates Emerging Markets PE and VC Funds.

As a highly active growth capital investor, TVM Capital Healthcare has invested and grown CMRC to be a sustainable healthcare business which continues to have a significant social impact on the communities it serves. CMRC is fully accredited by some of the world’s top clinical excellence accreditation organizations, such as Joint Commission International (JCI) and CARF and is considered a pioneer in post-acute services in its region. CMRC today has a capacity of 250 licensed beds and out-patient facilities. More recently during the global Covid-19 pandemic, CMRC demonstrated the benefits of specialist care outside of hospitals, relieving the public health system by unblocking acute beds and delivering quality outcomes for the post-acute patients it took on.

Dr. Helmut Schuehsler, Chairman and CEO of TVM Capital Healthcare, commented: In 2010, we identified a major unmet need in the region’s healthcare sector. Through the first long-term care company we invested in – ProVita International Medical Center, exited in 2015 with a 10.7x return on capital invested - and two years later in 2012, through CMRC – we introduced highly specialized long-term medical care, rehabilitation, and outpatient services. Today, we are extremely proud of the value we created with CMRC for patients, their families, the local healthcare system, and our investors – by building a centre of healthcare excellence leveraging our 35 plus years of global healthcare experience, our global network, and the expertise of alliance partners such as Spaulding Rehabilitation Network, official teaching partner of the Harvard Medical School Department of Physical Medicine and Rehabilitation.”

Hoda Abou-Jamra, Founding Partner of TVM Capital Healthcare and Managing Director Southeast Asia, added: “Our early and continued focus on installing quality and a comprehensive ESG framework has enabled us to build a sustainable and successful healthcare company that not only has created more than 500 jobs to date but also has significantly supported its community. Our team in Southeast Asia is transferring our post-acute care, and other specialty care expertise, to selected Southeast Asian markets, where we see similar demand.”

Carl Stanifer, Operating Partner of TVM Capital Healthcare and current Chairman of CMRC, said: “I am proud to have been part of the CMRC journey in becoming one of the leading post-acute care providers in the region, which perfectly proof-points our investment strategy. Looking forward, Southeast Asia will offer TVM Capital Healthcare ample opportunity to execute on its post-acute care expertise. We see promising investment opportunities there in meeting specific, underserved healthcare needs in certain segments and areas in the region where the firm potentially could add operational value.”

Dr. Mohamad Hamade, CEO of Amanat, concluded: “CMRC has been built from the ground up into what is now considered a leading post-acute care and rehabilitation center (“PAC”) with more than 250-beds across three facilities in the UAE and KSA. TVM Capital Healthcare has done an excellent job in supporting the management team over the years, creating this profitable and scalable business and as part of our own strategy, we will integrate CMRC alongside Sukoon, to create the GCC’s largest PAC platform.”

About TVM Capital Healthcare

TVM Capital Healthcare is an emerging markets-focused healthcare private equity investment firm. The firm invests growth capital in healthcare companies with a focus on specialized healthcare services, digital health solutions, pharmaceuticals, medical devices, and diagnostics. Investment and operating partners have strong international track records in healthcare M&A and operations. Headquartered in Singapore and Dubai, with representative offices in Munich and Boston, the firm partners with Middle East and Southeast Asia management teams to build sector champions and selectively backs companies from regions such as Europe or North America with expansion projects into the firm’s target geographies. TVM Capital Healthcare’s investment approach combines strong commercial value creation and returns with responsible investing and a comprehensive ESG framework to build impactful, sustainable, and well-governed companies, delivering excellent healthcare services, with continued growth and job creation, in a fair and diverse workplace, with high business ethics.

www.tvmcapitalhealthcare.com 

Media Contact TVM Capital Healthcare

Monika Schlesinger, TVM Capital Healthcare

schlesinger@tvmcapitalhealthcare.com

Brunswick Gulf on behalf of TVM Capital Healthcare

Charlie May, +971 50 467 3067

TVMCAPITAL@brunswickgroup.com

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.

More From Press Releases